Moxifloxacin (hydrochloride monohydrate)

Moxifloxacin (hydrochloride monohydrate)

• CAS Number: 192927-63-2
• UNSPSC Description: Moxifloxacin (BAY 12-8039) hydrochloride monohydrate is an orally active bacterial inhibitor that is effective against Streptococcus pneumoniae. Moxifloxacin hydrochloride monohydrate can be used in tuberculosis research[1][2].
• Target Antigen: Antibiotic; Bacterial
• Type: Biochemical Assay Reagents
• Related Pathways: Anti-infection
• Applications: COVID-19-immunoregulation
• Field of Research: Infection; Cancer
• Assay Protocol: https://www.medchemexpress.com/moxifloxacin-hydrochloride-monohydrate.html
• Solubility: 10 mM in DMSO
• Smiles: O=C(C1=CN(C2CC2)C3=C(C=C(F)C(N(C4)C[C@]5([H])[C@@]4([H])CCCN5)=C3OC)C1=O)O.Cl.O
• Molecular Weight: 455.91
• References & Citations: [1]Pestova E, et al. Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones. J Antimicrob Chemother. 2000 May;45(5):583-90.|[2]Miyazaki E, et al. Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis. Antimicrob Agents Chemother. 1999 Jan;43(1):85-9.
• Shipping Conditions: Room temperature
• Clinical Information: Phase 4